Interdisciplinary Medicine

Interdisciplinary Medicine is an open access peer-reviewed journal co-published by Wiley-VCH and Nanfang Hospital of Southern Medical University since 2022 that covers interdisciplinary biomedical research, with print ISSN 2832-6237 and online ISSN 2832-6245, and its 2025 Journal Impact Factor is 14.5（Interdisciplinary Medicine）是由（Wiley-VCH）与（Nanfang Hospital）、（Southern Medical University）自 2022 年起联合出版的开放获取同行评审期刊，聚焦交叉生物医学研究，印刷 ISSN 为 2832-6237，在线 ISSN 为 2832-6245，2025 年影响因子为 14.5。

Scope

• It publishes trailblazing significant works from any field of biomedicine that present an interdisciplinary dimension该刊发表生物医学各领域中具有交叉维度的重要创新成果。^[1]
• Topics of particular interest include laboratory medicine, biomaterials, computational biology, imaging and nuclear medicine, nanobiotechnology and tissue engineering重点关注的主题包括检验医学、生物材料、计算生物学、影像与核医学、纳米生物技术与组织工程。
• It provides a platform for the intersection of medical fields with science and technological innovation它为医学领域与科学技术创新的交汇提供平台。
• It aims to publish rapidly, giving validated interdisciplinary findings timely visibility该刊追求快速出版，使经审核的交叉研究成果及时获得可见度。
• It also carries reviews and perspectives bridging medicine with chemistry, physics, information science and materials science该刊还刊载连接医学与化学、物理学、信息科学与材料科学的综述与观点文章。
• In the 2025 Journal Citation Reports it is a Q1 title in Medicine, Research and Experimental on the Emerging Sources Citation Index, ranking eighth of 191在 2025 年（Journal Citation Reports）中，它是（Medicine, Research and Experimental）类别（ESCI）的 Q1 期刊，位列 191 种期刊中的第 8 位。

History

• It was co-founded by Nanfang Hospital of Southern Medical University and Wiley in 2022, with its first issue appearing in 2023该刊由（Nanfang Hospital）、（Southern Medical University）与（Wiley）于 2022 年联合创办，第一期于 2023 年面世。^[2]
• Its inaugural editorial by editor in chief Lei Zheng set out the aim to bridge the gaps between medicine and other disciplines其创刊社论由主编（Lei Zheng）撰写，阐明了弥合医学与其他学科之间鸿沟的目标。
• It was accepted into the Directory of Open Access Journals in July 2023该刊于 2023 年 7 月被（Directory of Open Access Journals）收录。
• Its Journal Impact Factor was 13.6 in 2024 and 14.5 in 2025其影响因子 2024 年为 13.6，2025 年为 14.5。
• By 2026 it had reached volume 4至 2026 年该刊已出至第 4 卷。
• It publishes six issues per year as a bimonthly journal该刊为双月刊，每年出版六期。

Editors

• Its editor in chief is Lei Zheng, Dean of the Department of Laboratory Medicine at Nanfang Hospital of Southern Medical University其主编为（Lei Zheng），系（Nanfang Hospital）、（Southern Medical University）检验医学系主任。
• Its honorary editors in chief are Ben Zhong Tang and Qian Wang其名誉主编为（Ben Zhong Tang）与（Qian Wang）。
• Its associate editors include Sai Kiang Lim, Jiashu Sun, Wen Wang, Kenneth W. Witwer and Zhen Zhao其副主编包括（Sai Kiang Lim）、（Jiashu Sun）、（Wen Wang）、（Kenneth W. Witwer）与（Zhen Zhao）。
• Editorial board members include Chunhai Fan, Xingyu Jiang, Ali Khademhosseini, Itamar Willner and Chaoyong Yang编委成员包括（Chunhai Fan）、（Xingyu Jiang）、（Ali Khademhosseini）、（Itamar Willner）与（Chaoyong Yang）。
• A consulting editor is Jose Oliveira, editor in chief of Small at Wiley, and the journal publisher is Vivian Zhang顾问编辑为（Jose Oliveira），系（Wiley）旗下（Small）的主编；期刊出版人为（Vivian Zhang）。^[3]